-
Type:
Change Request
-
Resolution: Not Persuasive with Modification
-
Priority:
Medium
-
FHIR Core (FHIR)
-
DSTU2
-
Clinical Genomics
-
MolecularSequence (was Sequence)
-
10.4.6
-
-
David Kreda/Clem McDownload: 25-0-2
-
Clarification
-
Non-substantive
-
DSTU2
Comment:
The sequence pointer must relate to the original definition of the variant. So is this a way to represent complex variants? If so, where do you represent the phase and where describe the type of complex variant. Does someone now report things this way for clinical decision support?
Summary:
sequence pointer
- is voted on by
-
BALLOT-3103 Negative - Clement McDonald : 2018-Sep-FHIR R1
- Balloted